Intellectual Property India Publishes Patent Application for 'Engineered Chimeric Fusion Protein Compositions And Methods Of Use Thereof' Filed by Create Medicines, Inc.

MUMBAI, India, March 14 -- Intellectual Property India has published a patent application (202617007007 A) filed by Create Medicines, Inc., Cambridge, U.S.A., on Jan. 23, for 'engineered chimeric fusion protein compositions and methods of use thereof.'

Inventor(s) include Getts, Daniel; Wang, Yuxiao; Gerber, Michele, Luise; and Maurer, Matthew, Anthony.

The application for the patent was published on March 13, under issue no. 11/2026.

According to the abstract released by the Intellectual Property India: "Compositions and methods for making and using engineered cells, such as, engineered myeloid cells that express a chimeric fusion protein that has a binding domain capable to binding surface molecules on target cells such as diseased cel...